Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
01/13/2004 | US6677335 Pharmaceutically active compounds |
01/13/2004 | US6677110 Dye-forming coupler, silver halide photographic light-sensitive material, and azomethine dye compound |
01/13/2004 | US6676976 Process for the production of vasicine |
01/08/2004 | WO2004002991A1 Porphyrin-polyamine conjugates for cancer therapy |
01/08/2004 | WO2004002986A2 Novel benzimidazole derivatives |
01/08/2004 | WO2004002964A1 Diaminopyrimidinecarboxa mide derivative |
01/08/2004 | WO2004002960A1 Substituted quinoline ccr5 receptor antagonists |
01/08/2004 | WO2004002406A2 Bicyclic pyrimidinones as coagulation cascade inhibitors |
01/08/2004 | WO2004002405A2 Amino-bicyclic pyrazinones and pyridinones |
01/08/2004 | WO2003090912A9 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
01/08/2004 | WO2003086315A3 Tyrosine kinase inhibitors |
01/08/2004 | WO2003080614A3 Triazolopyrimidines used as fungicides |
01/08/2004 | WO2003061604A3 Novel alkyl/aryl hydroxy or keto thiepines. |
01/08/2004 | WO2003055856A3 BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) |
01/08/2004 | WO2003028628A3 Photosensitizing carbamate derivatives |
01/08/2004 | US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones |
01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
01/08/2004 | US20040006101 Quinolinone derivatives |
01/08/2004 | US20040006096 Substituted alkanohydroxamic acids and method of reducing TNFalpha levels |
01/08/2004 | US20040006083 Pyrazolopyrimidines as therapeutic agents |
01/08/2004 | US20040006080 Chemical compounds |
01/08/2004 | US20040006078 For therapy of autoimmune diseases, asthma, osteoporosis, atherosclerosis, Alzheimer's disease |
01/08/2004 | US20040006066 Ring fused pyrazole derivatives as CRF antagonists |
01/08/2004 | US20040006065 Bicyclic pyrimidinones as coagulation cascade inhibitors |
01/08/2004 | US20040006064 For therapy of cancers, leukemias, parasites and as reversal agents of harringtonines |
01/08/2004 | US20040006063 Dipeptide derivatives |
01/08/2004 | US20040006054 Cytotoxic N-unsubstituted indoles and cyclopent(b)indoles and method of making and using same |
01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
01/08/2004 | DE19501377B4 Verfahren zur Herstellung von trans-1,4,5,8-Tetranitro-1,4,5,8-tetraazadecalin (TNAD) The method for producing trans-1,4,5,8-tetranitro-1,4,5,8-tetraazadecalin (tNAD) |
01/08/2004 | DE10327492A1 Optisches Verfahren zum Messen der Sauerstoffkonzentration und optischer Sensor zum Messen der Sauerstoffkonzentration An optical method for measuring the oxygen concentration and optical sensor for measuring the oxygen concentration |
01/08/2004 | DE10227507A1 Kationisch substituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Cationically substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
01/08/2004 | DE10227506A1 Ringsubstituierte Diphenylazetidinone, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung Ring-substituted Diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use |
01/08/2004 | DE10226943A1 Phenylaminopyrimidine und ihre Verwendung Phenylaminopyrimidine and their use |
01/08/2004 | CA2490298A1 Porphyrin-polyamine conjugates for cancer therapy |
01/08/2004 | CA2489560A1 Substituted quinoline ccr5 receptor antagonists |
01/07/2004 | EP1378570A1 Flk-1 is a receptor for vascular endothelial growth factor |
01/07/2004 | EP1378511A1 Process for the continous preparation of Acetylenediureine |
01/07/2004 | EP1378267A1 Use of flumazenil to produce a medicament for the treatment of cocaine dependency |
01/07/2004 | EP1378246A1 Remedies for arteriosclerosis |
01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
01/07/2004 | EP1377586A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
01/07/2004 | EP1377585A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
01/07/2004 | EP1377584A1 Novel cyclohexenyl phenyl diazepines as vasopressin and oxytocin receptor modulators |
01/07/2004 | EP1377583A1 Novel tricyclic hydroxy carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
01/07/2004 | EP1377582A1 Novel 3-c(o)r substituted 10-cyclohexylbenzoyl pyrrolobenzodiazepines; tocolytic oxytocin receptor antagonists |
01/07/2004 | EP1377581A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereof as tocolytic oxytocin receptor antagonists |
01/07/2004 | EP1377580A2 Benzenesulfonic acid indol-5-yl esters as antagonists of the 5-ht6 receptor |
01/07/2004 | EP1377577A1 Pyrrole derivates for treating cytokine mediated diseases |
01/07/2004 | EP1377567A1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
01/07/2004 | EP1377556A1 Pyrazole derivatives for treating hiv |
01/07/2004 | EP1377549A1 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor |
01/07/2004 | EP1377296A2 Antiviral method of use |
01/07/2004 | EP1377220A1 Fluorescent cobalamins and uses thereof |
01/07/2004 | CN1465576A Preparation for C60 polyazepine derivative |
01/06/2004 | US6673940 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids |
01/06/2004 | US6673927 Farnesyl transferase inhibitors |
01/06/2004 | US6673924 1,2,4-triazolol[4,3-a][1,3,5]triazine-3,5,7-substituted precursor, and process, and compounds therefrom |
01/06/2004 | US6673825 Urazole compounds useful as anti-inflammatory agents |
01/06/2004 | US6673810 Anticoagulants |
01/06/2004 | US6673802 Cardiovascular disorders; central nervous system disorders |
01/06/2004 | US6673798 PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
01/06/2004 | US6673797 Cyclooxygenase-2 inhibitors; treating inflammatory disease induced by cyclooxygenase-2 |
01/06/2004 | CA2093630C Pyrroloazepine compound |
01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
01/02/2004 | EP1375482A1 Benzamidine derivative |
01/02/2004 | EP1374952A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
01/02/2004 | EP1374897A1 Chlorin and bacteriochlorin-based difunctional aminophenyl DTPA and N2S2 conjugates |
01/02/2004 | EP1373274A1 A process for synthesis of a porphyrin compound using a molecular sieve catalyst under microwave irradiation |
01/02/2004 | EP1373272A2 Tert. alkylphenoxy substituted polycyclic compounds |
01/02/2004 | EP1373270A1 Tricyclic quinoxaline derivatives as a uv filter |
01/02/2004 | EP1373269A1 Jun kinase inhibitors |
01/02/2004 | EP1373268A2 Method for the manufacture of anagrelide |
01/02/2004 | EP1373251A2 Non-imidazole compounds as histamine h3 antagonists |
01/02/2004 | EP1373247A2 Spiroisoquinoline compounds, methods for their preparation and intermediates thereof |
01/02/2004 | EP1373233A1 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
01/02/2004 | EP1373224A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
01/02/2004 | EP1373222A2 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
01/02/2004 | EP1372656A1 Pyrazolo[4,3-d]pyrimidinone compounds as cgmp pde inhibitors |
01/02/2004 | EP1372655A2 Cathepsin cysteine protease inhibitors |
01/02/2004 | EP1372620A2 Methods for restoring cognitive function following systemic stress |
01/02/2004 | EP1235830B1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS AS PROTEIN KINASES INHIBITORS |
01/02/2004 | EP0976753B1 [1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE DERIVATIVES |
01/01/2004 | US20040002607 Sharp images; color photography |
01/01/2004 | US20040002602 Synthetic process for the manufacture of an ecteinaschidin compound |
01/01/2004 | US20040002528 CBI analogs of CC-1065 and the duocarmycins |
01/01/2004 | US20040002513 3-Substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
01/01/2004 | US20040002496 Compositions useful as inhibitors of protein kinases |
01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
12/31/2003 | WO2004000845A1 Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
12/31/2003 | WO2004000844A1 Pyrazolopyrimidines and the use thereof for controlling harmful organisms |
12/31/2003 | WO2004000843A1 NOVEL PURINE- OR PYRROLOL[2,3-d]PYRIMIDINE-2-CARBONITILES FOR TREATING DISEASES ASSOCIATED WITH CYSTEINE PROTEASE ACTIVITY |
12/31/2003 | WO2004000841A1 Hetero-bicyclic compounds |
12/31/2003 | WO2004000840A2 Quinuclidine derivatives and pharmaceutical compositions containing the same |
12/31/2003 | WO2004000832A1 1-[(indol-3-yl)carbonyl] piperazine derivatives |
12/31/2003 | WO2004000819A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives |
12/31/2003 | WO2004000804A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
12/31/2003 | WO2004000803A1 Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof |
12/31/2003 | WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly |
12/31/2003 | WO2004000800A2 Electrochromic salts, solutions, and devices |
12/31/2003 | WO2004000308A1 Method of photodynamic diagnosis for vascular diseases |